))
Ep 3 - Open Source, Open Science
Manage episode 327347909 series 3330201
Το περιεχόμενο παρέχεται από το Texere Publishing. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Texere Publishing ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
As the series nears its midway point, we are going open source. First we’ll talk to Ben Perry and Andrea Vernall about DNDi’s Open Synthesis Network for drug discovery, and then we’ll venture into the academy to speak with one of the students contributing to the Network. Information wants to be free, man, so hit play and learn a thing or two!
Ben Perry is the Discovery Open Innovation Leader for DNDi. He can be found on twitter at @MrBenGP
Andrea Vernall is a Senior Lecturer in the Department of Chemistry at the University of Otago. She can be found on Twitter at @andreav_otago
Aaron Mothersole is an MRes Drug Discovery and Development Researcher at Imperial College London
Mentioned in the episode
- the DNDi Open Synthesis Network
- the open source philosophy and the open science philosophy
- ‘Warhead’ molecules in cancer therapy
Read more from the sharpest minds in pharma at
themedicinemaker.com
If you have thoughts on anything you heard in this episode and want to share them or contribute to the magazine, then drop me an email at angus.stewart@texerepublishing.com
7 επεισόδια
Μοίρασέ το
